MTCR logo

Metacrine (MTCR) EBITDA

Annual EBITDA

-$60.03 M
-$24.67 M-69.77%

December 31, 2021


Summary


Performance

MTCR EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherMTCRprofitabilitymetrics:

Quarterly EBITDA

-$4.97 M
+$780.00 K+13.56%

September 30, 2022


Summary


Performance

MTCR Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherMTCRprofitabilitymetrics:

TTM EBITDA

-$35.77 M
+$12.86 M+26.45%

September 30, 2022


Summary


Performance

MTCR TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherMTCRprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

MTCR EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-69.8%+72.1%+37.8%
3 y3 years-140.2%+39.1%-136.9%
5 y5 years-140.2%+39.1%-136.9%

MTCR EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat lowat high+158.0%at high+67.9%
5 y5-year+116.3%at lowat high+258.7%+136.9%+67.9%
alltimeall time+140.2%at lowat high+258.7%+338.1%+67.9%

Metacrine EBITDA History

DateAnnualQuarterlyTTM
Sep 2022
-
-$4.97 M(-13.6%)
-$35.77 M(-26.4%)
Jun 2022
-
-$5.75 M(-52.9%)
-$48.63 M(-16.1%)
Mar 2022
-
-$12.22 M(-4.7%)
-$57.97 M(-3.4%)
Dec 2021
-$60.03 M(+69.8%)
-$12.82 M(-28.1%)
-$60.03 M(+4.4%)
Sep 2021
-
-$17.83 M(+18.1%)
-$57.53 M(+19.2%)
Jun 2021
-
-$15.10 M(+5.7%)
-$48.26 M(+14.9%)
Mar 2021
-
-$14.28 M(+38.4%)
-$42.00 M(+18.8%)
DateAnnualQuarterlyTTM
Dec 2020
-$35.36 M(+27.4%)
-$10.32 M(+20.5%)
-$35.36 M(+10.6%)
Sep 2020
-
-$8.56 M(-3.2%)
-$31.98 M(+1.3%)
Jun 2020
-
-$8.84 M(+15.7%)
-$31.58 M(+38.9%)
Mar 2020
-
-$7.64 M(+10.2%)
-$22.73 M(+50.6%)
Dec 2019
-$27.76 M(+11.1%)
-$6.93 M(-15.1%)
-$15.10 M(+84.9%)
Sep 2019
-
-$8.16 M
-$8.16 M
Dec 2018
-$24.99 M
-
-

FAQ

  • What is Metacrine annual EBITDA?
  • What is the all time high annual EBITDA for Metacrine?
  • What is Metacrine annual EBITDA year-on-year change?
  • What is Metacrine quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Metacrine?
  • What is Metacrine quarterly EBITDA year-on-year change?
  • What is Metacrine TTM EBITDA?
  • What is the all time high TTM EBITDA for Metacrine?
  • What is Metacrine TTM EBITDA year-on-year change?

What is Metacrine annual EBITDA?

The current annual EBITDA of MTCR is -$60.03 M

What is the all time high annual EBITDA for Metacrine?

Metacrine all-time high annual EBITDA is -$24.99 M

What is Metacrine annual EBITDA year-on-year change?

Over the past year, MTCR annual EBITDA has changed by -$24.67 M (-69.77%)

What is Metacrine quarterly EBITDA?

The current quarterly EBITDA of MTCR is -$4.97 M

What is the all time high quarterly EBITDA for Metacrine?

Metacrine all-time high quarterly EBITDA is -$4.97 M

What is Metacrine quarterly EBITDA year-on-year change?

Over the past year, MTCR quarterly EBITDA has changed by +$12.86 M (+72.12%)

What is Metacrine TTM EBITDA?

The current TTM EBITDA of MTCR is -$35.77 M

What is the all time high TTM EBITDA for Metacrine?

Metacrine all-time high TTM EBITDA is -$8.16 M

What is Metacrine TTM EBITDA year-on-year change?

Over the past year, MTCR TTM EBITDA has changed by +$21.76 M (+37.83%)